We are live on ! Find out more
AI

Atria Investments Portfolio holdings

AUM $9.98B
1-Year Est. Return 26.5%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+26.5%
3 Year Est. Return
+76.3%
5 Year Est. Return
+88.62%
10 Year Est. Return
+324.13%
AUM
$8.8B
AUM Growth
+$47.9M
Cap. Flow
-$77.2M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.4%
Holding
2,149
New
146
Increased
897
Reduced
969
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 14.13%
2 Financials 8.3%
3 Healthcare 6.22%
4 Industrials 5.62%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
76
TJX Companies
TJX
$178B
$19.9M 0.23%
129,606
-4,834
-4% -$715K
SHYG icon
77
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
$19.7M 0.22%
458,820
+19,312
+4% +$829K
KO icon
78
Coca-Cola
KO
$375B
$19.4M 0.22%
277,739
-7,688
-3% -$536K
SCHG icon
79
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$19.3M 0.22%
592,981
-58,851
-9% -$1.91M
SPSB icon
80
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
$19.3M 0.22%
638,633
+93,814
+17% +$2.84M
UNH icon
81
UnitedHealth
UNH
$370B
$19.3M 0.22%
58,415
-1,106
-2% -$375K
DGRO icon
82
iShares Core Dividend Growth ETF
DGRO
$43.6B
$19.2M 0.22%
276,573
+56,085
+25% +$3.86M
MRK icon
83
Merck
MRK
$318B
$19.1M 0.22%
180,988
+1,339
+0.7% +$126K
PG icon
84
Procter & Gamble
PG
$339B
$18.9M 0.21%
131,965
-10,579
-7% -$1.56M
TMO icon
85
Thermo Fisher Scientific
TMO
$220B
$18.8M 0.21%
32,421
-825
-2% -$467K
MCD icon
86
McDonald's
MCD
$195B
$18.8M 0.21%
61,381
+805
+1% +$247K
PH icon
87
Parker-Hannifin
PH
$135B
$18.7M 0.21%
21,265
-420
-2% -$344K
IAU icon
88
iShares Gold Trust
IAU
$64.4B
$18.6M 0.21%
228,581
+3,685
+2% +$288K
DIS icon
89
Walt Disney
DIS
$181B
$18.3M 0.21%
160,745
-27,535
-15% -$3.03M
ABT icon
90
Abbott
ABT
$187B
$18M 0.2%
143,442
-28,526
-17% -$3.63M
GS icon
91
Goldman Sachs
GS
$303B
$17.9M 0.2%
20,385
-1,551
-7% -$1.27M
AXP icon
92
American Express
AXP
$230B
$17.8M 0.2%
48,176
-1,619
-3% -$579K
SCHW
93
Charles Schwab
SCHW
$187B
$17.7M 0.2%
177,296
-4,272
-2% -$405K
SPDW icon
94
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.7B
$17.6M 0.2%
396,652
-10,477
-3% -$458K
CRM icon
95
Salesforce
CRM
$158B
$17.6M 0.2%
66,479
+2,326
+4% +$578K
QCOM icon
96
Qualcomm
QCOM
$176B
$17.4M 0.2%
101,680
-9,855
-9% -$1.69M
QQQM icon
97
Invesco NASDAQ 100 ETF
QQQM
$102B
$17.4M 0.2%
68,756
+11,728
+21% +$2.96M
IUSV icon
98
iShares Core S&P US Value ETF
IUSV
$27.7B
$17.4M 0.2%
169,310
-10,633
-6% -$1.08M
AMGN icon
99
Amgen
AMGN
$222B
$17.1M 0.19%
52,324
+10,877
+26% +$3.45M
FSMD icon
100
Fidelity Small-Mid Multifactor ETF
FSMD
$2.6B
$17M 0.19%
385,746
+3,773
+1% +$165K

Similar funds

Atria Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Atria Investments held 2,149 positions worth $8.8B, up 0.55% from $8.75B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Atria Investments's Q4 2025 filing shows 146 new, 897 increased, 969 reduced and 131 closed positions. Its largest new stake was JPMorgan Core Plus Bond ETF: 238,578 shares worth $11.3M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $23M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Atria Investments's largest Q4 2025 buy was JPMorgan Core Plus Bond ETF: 238,578 shares worth $11.3M.
  • Atria Investments added most to iShares S&P 500 Value ETF in Q4 2025, an estimated $22.2M increase.
  • Atria Investments's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $23M.
  • Atria Investments fully exited FT Vest US Equity Buffer ETF February in Q4 2025, selling an estimated $6.19M.
  • Atria Investments's ten largest holdings make up 14% of its $8.8B portfolio in Q4 2025.
  • Atria Investments opened 146 new positions and closed 131 in Q4 2025.
  • Atria Investments's portfolio value rose 0.55% quarter-over-quarter to $8.8B.

Based on Atria Investments's 13F filing for Q4 2025, filed 5 Feb 2026.